Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse
W H Berrettini1, M R Hoehe1, T N Ferraro1
1Department of Psychiatry, Pharmacology, Thomas Jefferson University, Philadelphia, PA, USADepartment of Pharmacology, Thomas Jefferson University, Philadelphia, PA, USAMax Delbruck Center of Molecular Medicine, Berlin, Germany.
Abstract:
Two polymorphisms of the human mu opioid receptor gene are described. A non-coding region polymorphism (G to T) occurs at nucleotide 175 preceding the initiation of translation. A coding polymorphism in exon 1 (C to T) at nucleotide 229 changes an alanine residue to a valine residue. Frequencies of these polymorphisms were examined in groups of cocaine and/or opioid dependent individuals and matched controls. There were no significant differences between groups, although a trend (p= 0.05) towards a higher frequency of the 229 valine allele was observed in the substance abuse group, suggesting a need for large, well-controlled studies of this polymorphism in severe substance abusers.
More Related Videos
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Opioid Receptors: Overview
Drug Abuse and Addiction: Pharmacological Phenomena
Analgesia and Pain Management
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Opioid Analgesics: Morphine and Other Natural Cogeners
